156 related articles for article (PubMed ID: 27614939)
1. The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis.
Adamo L; Tang Y; Nassif ME; Novak E; Jones PG; LaRue S; Spertus JA; Mann DL
JACC Heart Fail; 2016 Dec; 4(12):950-958. PubMed ID: 27614939
[TBL] [Abstract][Full Text] [Related]
2. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.
Adamo L; Nassif M; Tibrewala A; Novak E; Vader J; Silvestry SC; Itoh A; Ewald GA; Mann DL; LaRue SJ
JACC Heart Fail; 2015 Apr; 3(4):283-90. PubMed ID: 25770410
[TBL] [Abstract][Full Text] [Related]
3. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
[TBL] [Abstract][Full Text] [Related]
4. The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices.
Cowger JA; Castle L; Aaronson KD; Slaughter MS; Moainie S; Walsh M; Salerno C
ASAIO J; 2016; 62(3):281-5. PubMed ID: 26955002
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
6. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
7. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy.
Menon AK; Mechelinck M; Unterkofler J; Goetzenich A; Autschbach R; Tewarie L; Moza A
Thorac Cardiovasc Surg; 2016 Sep; 64(6):475-82. PubMed ID: 26501222
[TBL] [Abstract][Full Text] [Related]
9. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
[TBL] [Abstract][Full Text] [Related]
10. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
[TBL] [Abstract][Full Text] [Related]
11. Impact of INTERMACS Profile on Clinical Outcomes for Patients Supported With the Total Artificial Heart.
Shah KB; Thanavaro KL; Tang DG; Quader MA; Mankad AK; Tchoukina I; Thacker LR; Smallfield MC; Katlaps G; Hess ML; Cooke RH; Kasirajan V
J Card Fail; 2016 Nov; 22(11):913-920. PubMed ID: 27131435
[TBL] [Abstract][Full Text] [Related]
12. Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients.
Caruso R; Verde A; Cabiati M; Milazzo F; Boroni C; Del Ry S; Parolini M; Vittori C; Paino R; Martinelli L; Giannessi D; Frigerio M; Parodi O
J Heart Lung Transplant; 2012 Jun; 31(6):625-33. PubMed ID: 22386451
[TBL] [Abstract][Full Text] [Related]
13. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
14. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome.
Cowger J; Shah P; Stulak J; Maltais S; Aaronson KD; Kirklin JK; Pagani FD; Salerno C
J Heart Lung Transplant; 2016 Apr; 35(4):440-8. PubMed ID: 26683809
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients.
Critsinelis AC; Lamba HK; Nguyen MT; Conroy JR; Cheema FH; Civitello AB; Delgado RM; Nair AP; Oberton SB; Rosengart TK; Frazier OH; Morgan JA; Chatterjee S
ASAIO J; 2020 May; 66(5):539-546. PubMed ID: 31335367
[TBL] [Abstract][Full Text] [Related]
16. Heart Failure Severity Stratification Beyond INTERMACS Profiles: A Step Toward Optimal Left Ventricular Assist Device Timing.
Cogswell R; Estep JD; Araujo-Gutierrez R; Masotti M; Majaraj V; Teigen L; Schultz J; John R; Martin CM; Trachtenberg B
ASAIO J; 2021 May; 67(5):554-560. PubMed ID: 33470635
[TBL] [Abstract][Full Text] [Related]
17. INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry.
Kittleson MM; Shah P; Lala A; McLean RC; Pamboukian S; Horstmanshof DA; Thibodeau J; Shah K; Teuteberg J; Gilotra NA; Taddei-Peters WC; Cascino TM; Richards B; Khalatbari S; Jeffries N; Stevenson LW; Mann D; Aaronson KD; Stewart GC;
J Heart Lung Transplant; 2020 Jan; 39(1):16-26. PubMed ID: 31522912
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of risk indices in continuous-flow left ventricular assist device patients.
Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256
[TBL] [Abstract][Full Text] [Related]
19. INTERMACS Profiles and Outcomes Among Non-Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction.
Samman-Tahhan A; Hedley JS; McCue AA; Bjork JB; Georgiopoulou VV; Morris AA; Butler J; Kalogeropoulos AP
JACC Heart Fail; 2018 Sep; 6(9):743-753. PubMed ID: 30098970
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
